Summary The results of 24 h food preference tests have suggested that learned food aversions may be involved in the development of anorexia in tumour bearing rats and in patients with cancer. We have performed similar tests over longer periods, up to 10 days, in male rats implanted with Leydig cell tumours, using semisynthetic diets containing differing proportions of fat, protein and carbohydrate.
Summary The results of 24 h food preference tests have suggested that learned food aversions may be involved in the development of anorexia in tumour bearing rats and in patients with cancer. We have performed similar tests over longer periods, up to 10 days, in male rats implanted with Leydig cell tumours, using semisynthetic diets containing differing proportions of fat, protein and carbohydrate.
Tumour growth caused anorexia (16-30% decrease in food intake) and cachexia (78% decrease in body fat and 18% decrease in body protein, but 16% increase in body water). Both tumour bearing and control rats preferred a high carbohydrate diet to a high fat diet regardless of their previous diet: tumour bearing rats showed no evidence of a learned food aversion in these experiments. Tumour bearing rats did show an initial preference for a novel high protein diet when this was offered as an alternative to the normal protein diet they had previously been consuming, but this apparent learned food aversion disappeared on the second day of the test and was in fact reversed on all the subsequent days of the test. However, tumour bearing rats did show a sustained preference for a novel low protein diet when this was offered as an alternative to the normal protein diet they had previously been consuming. These results suggest that anorexia in the tumour bearing rats was not caused by a learned food aversion. However the results do indicate that the tumour bearing rats may have developed a specific aversion to protein in the diet.
Leydig cell tumours are known to secrete large amounts of oestradiol. However injections of oestradiol in normal male rats caused an increase in body fat content and had no effect on the rats' preference for dietary protein. Clearly hypersecretion of oestradiol was not responsible for the loss of body fat, the fluid retention and the aversion to dietary protein which characterised the tumour bearing rats. The mechanisms by which tumour growth causes anorexia and cachexia in these rats remains obscure. *
The major cause of death in patients with cancer is the existence of learned food aversions for periods up to ten generalised body wasting known as cachexia. This syndrome days in tumour bearing rats. Since it became clear during is characterised by abnormally low food intake together with these studies that factors other than previous diet were inappropriately high energy expenditure. Although much is governing the sustained food preference of our tumour now known about the metabolic abnormalities which bearing rats we examined systematically their preferences for underlie the elevation of energy expenditure, considerably the major components of the semisynthetic diets we were less is known about the decrease in food intake which many using, viz. protein, fat and carbohydrate. workers now regard as the primary event in the onset of Bernstein and Fenner (1983) found that these food cancer cachexia (Lindmark et al., 1984; Morrison, 1979) .
aversions did not occur in all tumour bearing rat models. We One feature of cancer anorexia which has been studied in therefore conducted our studies using a transplantable both man and the rat is the occurrence of 'learned food Leydig cell tumour growing in Fischer F344 rats. This aversions'. A learned food aversion is the unconscious should correspond closely with the transplantable Leydig cell association (by a person or an animal) of the consumption tumour growing in Wistar-Furth rats in which Bernstein and of a particular food with a concurrent or subsequent Fenner (1983) were able to demonstrate short term food unpleasant reaction. Thus a cancer-bearing rat comes to aversions. We monitored the growth rate, total food intake associate the growth of the tumour with the diet which it has and body composition of the rats to ascertain that this was a consumed during tumour growth, and if it is then offered a suitable model for the anorexia and cachexia of human choice between this diet and a different diet it shows an cancer. In some of the studies we used Sprague-Dawley rats, immediate preference for the new diet (Bernstein & which were more readily available, when we found that the Sigmundi, 1980) . The introduction of this new diet also tumour grew equally well in them and had the same effects causes at least a transient increase in total food conon food intake and body composition. The Leydig cell sumption. Similar studies in man have shown that when tumour is known to secrete large quantities of oestrogens, so children and adults with cancer were given a distinctively we examined the extent to which this could account for any flavoured ice-cream immediately prior to a dose of chemo-of the effects observed in the tumour bearing rats by therapy they developed an unconscious aversion to that administering exogenous oestradiol to normal rats. flavour of ice-cream (Bernstein & Webster, 1980) . Subsequent studies have identified aversions to many normal components of patients' regular diets (Bernstein & Bernstein, Materials and methods 1981) .
These studies have only investigated food preference at a Animals single meal (in cancer patients) or over a single day (in tumour bearing rats). If learned food aversions do play a Male Fisher F344 rats from OLAC Ltd (Bicester, Oxon.) causal role in the aetiology of cancer anorexia they must weighing 180-200 g were used in Experiments 1 and 2; male presumably continue to exist for as long as the patient or Sprague-Dawley rats from the QEC colony (this institute) animal remains anorectic. We have therefore monitored the weighing 150-170 g were used in Experiments 3-5. The rats __________________________________________ were housed individually in wire-bottomed cages suspended for at least two days, and were continued for ten days. At From day 21-30 the rats were given a food preference test Time (days) (as in xperimnt 1) btween iets LFand HF Figure 1 Mean body weights of tumour bearing ---and control -rats in a typical experiment (Experiment 3)..
Experiment 5 Twenty-four rats were randomly allocated to represents the calculated values for the weight of the host tissues 4 groups of 6. Each rat was then given daily s.c. injections of of the tumour bearing rats, assuming linear tumour growth from oestradiol suspended in a slow-release vehicle as described by day 17, when the tumour became palpable. (Emery et al., 1986) . Cardiac muscle, however, experiment. The variation may have been caused by appears to be relatively protected from wasting during differences in the concentration of tumour cells in the cancer cachexia, as it is in starvation (Emery et al., 1983) . suspension prepared at the start of each experiment for The effects of tumour growth on body weight, food intake injecting into the rats. and body composition of the rats in these experiments was The growth of the tumour was always accompanied by a similar to the effects observed in similar rats maintained reduction in food intake but the rate of total body weight entirely on diet NP (Emery et al., unpublished observations). gain was not always reduced. This was partly because the Table III summarises the effects of administation of loss of host tissue was to some extent offset by the growth of oestradiol to normal male rats. The plasma oestradiol the tumour, but also because the tumour bearing rats were concentration of group A rats (1040 +400 pg ml-1) was not retaining excessive amounts of fluid (Table II) . Clearly the significantly different from that of tumour bearing rats rate of loss of body weight will not always be a reliable (1030+250pgml-1). This dose of oestradiol caused a 17% guide to the extent of cachexia in human cancer patients reduction in food intake but only a 7% reduction in weight who may also retain fluid.
gain. Moreover the body composition of the oestradiol Table II summarises the effect of tumour growth on host treated rats was quite different from that of either normal body composition in the animals from Experiments 1-4. The rats or tumour bearing rats. Protein content was reduced by tumour represented only 7.4% of the animal's final body 17% but fat content was increased by 72% in group A weight. Skeletal muscle was severely wasted, as shown by the compared with control rats. Thus whereas the reduction in 20% reduction in gastrocnemius muscle weight of tumour food intake and loss of lean body mass by tumour bearing bearing rats compared with controls. There was also a 26% rats might be partially attributable to the effect of oestradiol reduction in the weight of the small intestine. In contrast, the massive loss of fat is obviously not. Oestrogen administhere was no difference in heart weight between the two tration has previously been reported to reduce food intake groups, while liver weight showed a 10% increase in the and weight gain in intact male rats (Moffitt et al., 1975) , possibly acting via an increase in corticosterone production 100 (Mook et al., 1972) whole 10 day period the tumour bearing rats consumed 81% of their food as NP, compared with 51% for the controls (P<0.01). statistically significant difference in food preference between
The apparent learned food aversion shown by the tumour the two groups on each of days 2-10; overall the tumour bearing rats was thus only a transient phenomenon. In the bearing rats consumed 18% of their food as NP compared longer term they actually showed a sustained preference for with 47% for the controls (P<0.01). These results suggest the familiar diet NP. This could be interpreted as a 'home that the tumour bearing rats had in fact developed a specific diet preference' or it could indicate a specific aversion to aversion to dietary protein. dietary protein in tumour bearing rats. These possibilities Experiments 3 and 4 were designed to investigate whether were therefore evaluated in Experiment 2 by testing tumour growth was associated with aversions to the other preference for a novel low protein diet against the familiar major nutrients in the diet, fat and carbohydrate. As shown diet NP. As shown in Figure 4 the tumour bearing rats in Figures 5 and 6 there was no consistent difference showed a sustained preference for the novel diet LP throughbetween tumour bearing and control rats in their preference out this experiment, whereas the controls showed an initial for HF and LF diets. All animals showed a sustained preference for LP on day I but then ate approximately equal preference for the low fat, high carbohydrate diet LF, amounts of the two diets on each of days 2-10. There was a regardless of which diet had been fed previously. In fact the tumour bearing rats did eat significantly less HF than the longer than 24 hours: the present results cast doubt on the controls on day 3 of Experiment 4 (P<0.05) and aetiological significance of those observations. significantly more HF than the controls on day 6 of the The major change in food preference which the tumour same Experiment (P<0.05). There was no obvious reason bearing rats showed was an aversion to a high protein diet for this anomalous behaviour on those days, and it does not and a preference for a low protein diet. In fact the protein alter the interpretation of the results. In Experiment 3 the source used in the diets was not pure protein but also tumour bearing rats ate, on average, 14% of their food as contained 1% fat, 2% lactose and 8% minerals, so it is not HF while the controls ate 18% HF (P=NS), and in impossible that the rats were actually trying to avoid one of Experiment 4 the tumour bearers ate 22% HF while the these components. However it is much more likely that the controls ate 24% HF (P=NS). Clearly tumour growth had tumour bearing rats were showing an aversion to dietary no effect on the rats' choice between these two iso-protein, and this may correspond to reports of human cancer nitrogenous diets.
patients developing a distaste for high protein foods, Experiment 5 was designed to investigate whether the particularly meat (De Wys, 1970) . aversion to a high protein diet shown by the tumour bearing Tumour bearing rats did not show any altered preference rats in Experiment 1 was caused by the high circulating for the major sources of energy in their diets, carbohydrate concentration of oestradiol. Figure 7 shows that this was not and fat. Both tumour bearers and controls showed a marked the case, since there was in fact no significant difference in preference for diet LF rather than HF. This may have been food preference between any of the groups of rats on any caused by the large amount of cellulose which was present in day. Over the 10 day test period the rats in group A, which HF in order to make the metabolisable energy density of received the highest dose of oestradiol, consumed 55% of these two diets equal. Large amounts of cellulose and other their food as NP, compared with 54% for group B, 47% for 'dietary fibres' can cause distension of the gastrointestinal group C, and 51% for the control group D. Clearly the tract and abdominal discomfort. effect of this Leydig cell tumour on food preference which The significance of these results for human cancer patients was observed in Experiment 1 was not mediated simply by depends to some extent on how closely this animal model hypersecretion of oestradiol. mimics the features of human cancer cachexia. Probably the most important point is that the tumour should not be too Discussion large in proportion to the host animal, since human tumours rarely grow to more than 5% of body weight (Costa, 1977) . The results of these experiments do not support the The tumours we used in these studies grew to 8% of the hypothesis that learned food aversions are important in the host body weight by the end of the experiments and caused a development of the anorexia which is characteristic of cancer sustained depression of food intake and a severe loss of cachexia. The results of the first day of Experiment 1 could protein and fat from the host body. This was thus a more have been interpreted as showing the existence of a learned appropriate model than, for instance, the most widely used food aversion in the tumour bearing rats but the subsequent animal tumour model, the Walker 256 carcinoma growing in behaviour of these rats showed that this was only a transient Sprague-Dawley rats, which can grow to more than 40% of phenomenon. The consistent preference of these rats for diet host body weight (Mider et al., 1948) .
NP throughout days 2-1O was the opposite of what would
The mechanism by which tumour growth causes changes have been observed if a learned food aversion had been in food preferences remains obscure, as indeed is the case for responsible for the anorexia caused by tumour growth.
other features of cancer cachexia. The main identifiable Previous investigations of learned food aversions in tumour humoral products secreted by Leydig cell tumours are bearing rats and patients (Bernstein & Sigmundi, 1980;  oestrogens, but Experiment 5 showed that raising the plasma Bernstein & Webster, 1980) did not test food preference for oestradiol concentration of normal rats to a level comparable to that of the tumour bearing animals did not have the same effect on food preference or body composition as tumour growth. If the anorexia and cachexia of cancer are indeed mediated through an as yet unidentified humoral substance it may be that this substance is in fact synthesised by host tissues in response to the presence of the tumour rather than by the tumour itself (Editorial, 1985) .
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